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Summary
Bis-(3,5)-cyclic-dimeric-guanosine monophosphate
(c-di-GMP) has been shown to be a global regulatory
molecule that modulates the reciprocal responses of
bacteria to activate either virulence pathways or
bioﬁlm formation. The mechanism of c-di-GMP signal
transduction, including recognition of c-di-GMP and
subsequent phenotypic regulation, remain largely
uncharacterized. The key components of these regu-
latory pathways are the various adaptor proteins
(c-di-GMP receptors). There is compelling evidence
suggesting that, in addition to PilZ domains, there
are other unidentiﬁed c-di-GMP receptors. Here we
show that the PelD protein of Pseudomonas aerugi-
nosa is a novel c-di-GMP receptor that mediates c-di-
GMP regulation of PEL polysaccharide biosynthesis.
Analysis of PelD orthologues identiﬁed a number of
conserved residues that are required for c-di-GMP
binding as well as synthesis of the PEL polysaccha-
ride. Secondary structure similarities of PelD to the
inhibitory site of diguanylate cyclase suggest that a
common fold can act as a platform to bind c-di-GMP.
The combination of a c-di-GMP binding site with a
variety of output signalling motifs within one protein
domain provides an explanation for the speciﬁcity
for different cellular responses to this regulatory
dinucleotide.
Introduction
Recently, bis-(3′,5′)-cyclic-dimeric-guanosine monophos-
phate (c-di-GMP) has been shown to be a central regu-
lator in bacterial physiology that reciprocally regulates
behaviour of bacterial communities (D’Argenio and Miller,
2004; Jenal, 2004; Romling et al., 2005; Romling and
Amikam, 2006). In several bacterial species, a rise in
c-di-GMP levels results in an increase in expression of
various factors necessary for the establishment and main-
tenance of bioﬁlm communities, whereas decrease in the
production of the cyclic dinucleotide or its cleavage
usually leads to enhanced expression of virulence and
motility factors. In this signalling cascade, a number of
controls exist to ensure proper responses to the levels of
cellular c-di-GMP including signal generation, signal deg-
radation and signal recognition. The level of c-di-GMP is
regulated by the opposing activities of diguanylate cycla-
ses (DGCs) that synthesize and phosphodiesterases
(PDEs) that degrade this signalling molecule (Paul et al.,
2004; Bobrov et al., 2005; Hickman et al., 2005; Schmidt
et al., 2005; Christen et al., 2006; Kulasakara et al., 2006;
Ryjenkov et al., 2006). These enzymes can be readily
identiﬁed by their conserved GG(D/E)EF and EAL motifs
respectively (Galperin et al., 2001) (Pfam Accession No.
PF00990 and PF00563). Studies in a number of patho-
genic bacteria have demonstrated the reciprocal relation-
ship of DGC and PDE activities including those in Vibrio
cholerae (Tamayo et al. 2005; Tischler and Camilli, 2005),
Salmonella typhimurium (Simm et al., 2004; Romling,
2005; Simm et al., 2005; Kader et al. 2006), Yersinia
pestis (Kirillina et al., 2004; Bobrov et al., 2005) and
Pseudomonas aeruginosa (Hickman et al., 2005;
Hoffman et al., 2005; Kulasakara et al., 2006).
The ﬁrst biological process shown to be dependent on
c-di-GMP was the production of cellulose in Gluconaceto-
bacter xylinus (Ross et al., 1987). In this system,
c-di-GMP acts as an allosteric activator for cellulose bio-
synthesis (Ross et al., 1990) by binding to the BcsA1
protein (Weinhouse et al., 1997), a component of the cel-
lulose synthase complex. BcsA1 contains a conserved
sequence that has been suggested to be the c-di-GMP
receptor, the so-called PilZ domain (Amikam and
Galperin, 2006). Recently, several proteins containing
PilZ domains have been shown to bind c-di-GMP
(Ryjenkov et al., 2006; Christen et al., 2007; Merighi
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However, it is likely that the number of different c-di-GMP-
binding domains may be far greater than those with PilZ
domains. There is evidence for the existence of protein
domains other than PilZ that are capable of binding to
c-di-GMP including the inhibitory site (I-site) of many
DGCs (Garcia et al., 2004; Kirillina et al., 2004; Christen
et al., 2006; Goymer et al., 2006; Malone et al., 2007) and
all PDEs that bind and hydrolyse the dinucleotide (Bobrov
et al., 2005; Schmidt et al., 2005; Christen et al., 2006;
Kulasakara et al., 2006).
A systematic analysis of P. aeruginosa genes encoding
DGCs and PDEs identiﬁed a phenotype that could not
be linked to known proteins that contain a PilZ domain
(Kulasakara et al., 2006; V.T. Lee, unpubl. data). In these
studies, overexpression of DGCs led to a rise in the levels
ofc-di-GMPandtheformationofmulticellularcommunities
(pellicles) at the air–surface interface of the bacterial
culture (Kulasakara et al., 2006). Pellicle formation in
P. aeruginosa requires proteins encoded in the pel and psl
operons to synthesize glucose and mannose-rich polysac-
charides, respectively (Friedman and Kolter, 2004a, b;
Jackson et al., 2004; Matsukawa and Greenberg, 2004;
Vasseuret al.,2005).Expressionofthepelgenesrequired
for PELpolysaccharide production in P. aeruginosa can be
induced by several mechanisms. One pathway occurs
through histidine kinases RetS and LadS that act in oppos-
ing manner on the GacA/GacS two-component system.
TheGacA/GacSsysteminturncontrolsthetranscriptionof
two small regulatory RNAs (srRNAs) rsmY and rsmZ
leading to a decrease or increase in the translation of the
pel operon transcripts in the presence of the RetS or LadS
signal respectively (Goodman et al., 2004; Ventre et al.,
2006). In a second pathway, increasing the levels of c-di-
GMP also results in the increased transcription of pel
operon expression as demonstrated by either overexpres-
sion of DGC (Kulasakara et al., 2006) or a mutation in
wspF, a gene encoding a methylesterase, that indirectly
elevates the levels of c-di-GMP presumably by affecting
the activity of WspR diguanylate cyclase (Hickman et al.,
2005).Analysis of mRNAlevels using microarrays showed
that the levels of various pel gene transcripts increased by
3- to 32-fold in P. aeruginosa DretS as compared with the
parental strain (Goodman et al., 2004) and deletion of
wspF resulted in comparable effect on pel transcripts
(Hickman et al., 2005). Therefore, expression of pel
genes and formation of the Pel polysaccharide appears
to be controlled by several transcriptional and post-
transcriptional mechanisms. However, there are no known
PilZ domain-containing proteins encoded by the pel
operon suggesting that another yet to determined protein
domain may interact directly with c-di-GMP.
Here we report that c-di-GMP directly affects the ability
of P. aeruginosa to form bioﬁlms by mediating the produc-
tion of the extracellular PELpolysaccharide. We show that
PelD, encoded by one of the genes within the pel operon,
speciﬁcally binds c-di-GMP. The expression of PelD and
its binding of c-di-GMP are required for PEL polysaccha-
ride production. A systematic analysis of the residues
important for c-di-GMP binding in PelD identiﬁed a unique
binding sequence that was conserved among many PelD
orthologues. Whereas PelD does not share any primary
sequence or secondary structural similarities to the known
c-di-GMP-binding PilZ domain, it appears to have the
conserved RxxD motif found in the I-site of PleD (Chan
et al., 2004; Christen et al., 2006; Malone et al., 2007).
However, the c-di-GMP-binding motif in PelD is distinct
from the I-site of DGCs which have been previously
shown to reside six to nine amino acids N-terminal to the
GGEEF motif of these enzymes (Christen et al., 2006).
Furthermore, c-di-GMP binding alters these proteins in a
distinct manner to activate PelD for PEL synthesis in
contrast to inhibition of diguanylate cyclase activity of
PleD. Identiﬁcation of a novel family of c-di-GMP-binding
proteins allows the understanding of the diverse biological
effects of this dinucleotide.
Results
Role of c-di-GMP in bioﬁlm formation is distinct from
the RetS signalling pathway
In-frame deletions of the pelA, pelD and pelE genes abro-
gated the ability of P. aeruginosa PA14 to produce bioﬁlms
in static culture in either the wild-type or DretS genetic
background (Fig. 1A and B) (Vasseur et al., 2005). These
results suggest that genes encoded by the pel operon are
essential for pellicle formation. Using a lacZ transcrip-
tional reporter fused to the pel promoter, we examined
whether manipulating the levels of c-di-GMP by overex-
pressing proteins that have been previously shown to
possess diguanylate cyclase activity would also effect the
transcription of the pel operon (Kulasakara et al., 2006).
In the wild-type PA14 parent carrying the pMMB vector
alone, approximately 200 Miller units of b-galactosidase
activity was detected and comparable expression of the
pel–lacZ fusion was observed in the DpelA, DpelD or
DpelE mutants (Fig. 1C). Induction of three independent
diguanylate cyclases, PA1107, PA1120 and PA3702
(WspR), resulted in an increase in pel transcription in
wild-type PA14 by ﬁve- to seven-fold, while in the DpelA,
DpelD or DpelE backgrounds, transcription also increased
by three-fold. These results indicate that high levels of
cellular c-di-GMP enhance the level of pel mRNA. In each
case, we consistently observed a higher induction of
b-galactosidase in wild-type P. aeruginosa PA14 com-
pared with DpelA, DpelD or DpelE mutants, suggesting a
role for the functional PEL biosynthetic complex in regu-
lating its own expression.
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elevated levels of pel transcripts and the strains overex-
pressing diguanylate cyclases appear to be qualitatively
different with more bioﬁlm material produced in the strains
that are overexpressing diguanylate cyclase (Fig. 1A and
B). We measured the amount of polysaccharide produced
by each strain using a Congo red binding assay in which
macromolecular polymers such as polysaccharides and
protein ﬁlaments can sequester Congo red (Spiers et al.,
2003). To account for the amount of bacteria in each
bioﬁlm, we normalized the Congo red binding to the
amount of total protein in each sample. Bioﬁlms, induced
by overexpression of PA3702 (wspR), bound
52.4  6.7 mgofCongoredpermgofprotein;however,the
bioﬁlm produced by the DretS strain bound only
10.7  0.6 mg of Congo red per mg of protein (Fig. 1D), a
ﬁve-folddecreaseascomparedwithDGCoverexpression.
pelD expression is required for pellicle production and
polysaccharide production; DpelD pMMB-PA3702 and
DretSDpelDstrainsboundonlyaminimalamountofCongo
red (3  2 mg of Congo red per mg of protein) (Fig. 1D).
Using chemical analyses, we have separately demon-
strated that Congo red binding to P. aeruginosa absolutely
correlates with pel-dependent production of a hexose-
containing polysaccharide (Table S1). These ﬁndings
demonstrate that even when high level of pel operon
transcript is present, it is the level of c-di-GMP which
controls the amount of PEL polysaccharide produced by
the bacteria and this signalling dinucleotide acts through
the proteins encoded by the pel operon.
Binding of c-di-GMP to proteins encoded by
the pel operon
One possible mechanism for post-transcriptional regula-
tion by c-di-GMP on increased pellicle production is by the
direct interaction of c-di-GMP with a component of the
PEL biosynthetic machinery encoded by the pel operon.A
search for the previously identiﬁed c-di-GMP-binding PilZ
domains among the pel-encoded proteins failed to identify
any such domain. Therefore, a direct c-di-GMP binding
assay was developed to assess the ability of recombinant
Pel proteins to bind c-di-GMP.
Analysis of the proteins encoded by the pel operon
indicates that PelA is a cytosolic protein, PelB is an outer
membrane protein, PelC is a periplasmic protein
(Lewenza et al., 2005), PelD and PelE are inner mem-
brane proteins with large cytosolic domains, PelF shares
homology to other glycosyltransferases and PelG is a
12-transmembrane inner membrane protein (Fig. S1).
The pel operon is conserved in a number of bacterial
species (Fig. S1). To determine whether any of the Pel
proteins bind c-di-GMP, we inserted the pel genes in
vectors that directed the synthesis of full-length PelA and
PelF, and fragments of PelC, PelD and PelE lacking trans-
membrane domains fused to an N-terminal 6-histidine tag
and maltose-binding protein (MBP). The puriﬁed proteins
(Fig. 2A) were assayed for binding to [32P]-c-di-GMP by
the ability of each protein bound to Ni-NTA agarose to
retain radioactivity. Only the PelD fusion protein was able
to retain [32P]-c-di-GMP (Fig. 2B). This interaction is spe-
ciﬁc as unlabelled c-di-GMP was able to block [32P]-c-di-
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Fig. 1. Phenotypic comparison of DretS mutation or overexpression
of diguanylate cyclase on pellicle production and pel mRNA levels.
A and B. Pellicle formation in static culture as revealed by crystal
violet staining for (A) PA14, PA14DpelA, PA14DpelD and
PA14DpelE harbouring vector control or induced for expression of
diguanylate cyclases PA1107, PA1120 or PA3702; (B) PA14DretS,
PA14DretSDpelA, PA14DretSDpelD and PA14DretSDpelE.
C. Expression of pel was determined by measuring b-galactosidase
levels using a pelA–lacZ reporter construct in strains PA14,
PA14DpelA, PA14DpelD and PA14DpelE harbouring vector control
or induced for expression of diguanylate cyclases PA1107, PA1120
or PA3702.
D. Quantiﬁcation of PEL polysaccharide by binding to Congo red
was normalized to total protein for strains PA14 pMMB-PA3702,
PA14DpelD pMMB-PA3702, PA14DretS and PA14DretSDpelD.
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CTP, GTP, UTP, GDP, GMP, cyclic-GMP and cyclic-AMP
did not compete for binding of the radiolabelled ligand
(Fig. 2C). Furthermore, PelD does not bind [3H]-cyclic-
GMP and [3H]-cyclic-AMP (Fig. S2). These results dem-
onstrate that PelD speciﬁcally binds only c-di-GMP.
Conserved residues in the C-terminal domain of PelD
are required for binding of c-di-GMP
Analysis of the PelD sequence using BLAST algorithms
identiﬁed gene clusters in different bacterial species that
encode PelD orthologues (Fig. 3A). Sequence alignment
of PelD orthologues revealed conservation of the four
transmembrane domains and an additional number of
highly conserved residues (Fig. 3A). To avoid disrupting
folding of the protein, we chose only hydrophilic and
charged amino acids in the region C-terminal to the trans-
membrane segments as indicated in the schematic in
Fig. 3B. The wild-type PelD and each of the point muta-
tions were expressed as fusions to 6-histidine-MBP and
were puriﬁed on Ni-NTA agarose (Fig. 3C). The puriﬁed
proteins, immobilized on Ni-NTA agarose, were then
tested for their ability to retain [32P]-c-di-GMP (Fig. 3D).
PelD with substitutions R131A, R161A, D305A and a
mutant with two substitutions, S145A/H146A, retained the
ability to bind [32P]-c-di-GMP, whereas proteins containing
R367A, D370A and R402A were unable to bind [32P]-c-di-
GMP. These results identify three critical charged resi-
dues in the C-terminus of PelD that are required for the
protein to bind c-di-GMP.
Affinity of PelD for cyclic-di-GMP
We determined the affinity of PelD for c-di-GMP using the
surface plasmon resonance technique. The MBP-PelD or
point mutant variants were chemically cross-linked onto
gold surface. Either c-di-GMP or GTP at 5, 10 or 20 mM
was passed over the protein-coated surface. An interac-
tion between the protein and ligand results in a mass
change of the complex that is detectable by a change in
the resonance frequency of the gold surface and is read
out as relative units (RU). MBP-PelD was able to bind
c-di-GMP with a dissociation constant (KD)o f1 mM
(Fig. 4A). Point mutants (R367A, D370A or R402A) were
not able to bind c-di-GMP (Fig. 4B–D respectively). None
of the MBP-PelD or point mutants bound GTP suggesting
that PelD is not a diguanylate cyclase. The theoretical
maximum response is proportional to the ratio of the
molecular weight of the ligand and the protein and the
number of binding sites for the ligand. As 6000 RU of
protein was cross-linked onto each spot of the chip, the
maximum response would be 50 RU for one c-di-GMP
binding site and 100 RU for two c-di-GMP binding site. As
the protein is chemically linked, it is very likely oriented in
many directions relative to the surface and thus only a
fraction, typically half, of the PelD would be available to
bind c-di-GMP. The amount of response for MBP-PelD
that approaches saturation is approximately 25 RU sug-
gesting that there is one c-di-GMP binding site per PelD
protein.
PelD contains a cyclic-di-GMP-binding motif
A Pfam search demonstrated that PelD lacked a recog-
nizable PilZ domain in contrast to the eight other
P. aeruginosa genes that encode PilZ domains. Second-
ary structure of PelD predicted by ProteinPredict (Rost
et al., 2004) suggest that the PelD protein consists of
alternating a-helix–b-sheet–a-helix–b-sheet–a-helix that
is distinct from the b-barrel fold of PilZ domains (Fig. 5A).
Another known c-di-GMP-binding domain is the I-site of
diguanylate cyclases that controls feedback inhibition as
demonstrated for Caulobacter crescentus PleD (Chan
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invariably located nine and six amino acids from the
GGEEF (Christen et al., 2006). Despite a low level of
sequence similarity between PelD and PleD, we sought to
determine whether there are any secondary structural
similarities between these two proteins. Secondary struc-
ture predicted by ProteinPredict produced results that
matched the known structure determined by crystallogra-
phy (Fig. 5) (Chan et al., 2004). An important component
of this computational analysis is the conﬁdence level
assigned for each of the predicted elements ranging from
0 to 9 with 9 being the greatest conﬁdence of the
prediction. Using alignment tools at Phyre web server
(http://www.sbg.bio.ic.ac.uk/phyre) (Kelley et al., 2000),
the conserved residues in PleD for the top 100 homo-
logues yielded a number of residues including the cata-
lytic GGEEF motif and the RxxD I-site and allow the
identiﬁcation of conserved identical and similar residues
(Fig. 5B). Mapping these residues on the crystal structure
of the PleD revealed that the GGEEF motif and all other
conserved residues map to one face of the diguanylate
cyclase domain, whereas the RxxD motif is on the other
face (Fig. S3). Comparison of the PelD and PleD second-
ary structures suggests that they have similar domain
fold consisting of alternating a-helix–b-sheet–a-helix–b-
sheet–a-helix (Fig. 5B). Furthermore, the RxxD residues
required for binding c-di-GMP are present in both proteins
at similar position within the domain (Fig. 5B). Despite
these similarities, PelD is obviously lacking the GG(D/E)F
motif of diguanylate cyclases as well as other conserved
residues. Furthermore, the equivalent of PelD R402 is
much less conserved in PleD-like homologues. Together
these results suggest the potential of a wide array of
proteins that can utilize a simple RxxD c-di-GMP-binding
motif to regulate the activity of other portions of the
protein.
PelD binding to c-di-GMP is required for
pellicle production
As pelD is required for pellicle production (Fig. 1A and B),
we sought to determine whether binding of c-di-GMP to
PelD is required for pellicle formation. A two-plasmid
system was used to constitutively express a diguanylate
cyclase (pDN19-PA3702), while pelD was induced from a
second plasmid (pMMB). PA14DpelD harbouring pDN19-
PA3702 was transformed with pMMB-Gn containing
wild-type pelD and mutated versions of pelD genes,
expressing PelD as a fusion protein with a C-terminal
haemaglutinin (HA) tag. Expression of PelD mutants with
R131A, R161A, D305A or S145A/H146A substitutions,
which were unaffected in their ability to bind c-di-GMP,
complemented the PA14DpelD mutant and restored its
ability to form a robust pellicle and bind Congo red
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Fig. 4. Affinity of PelD for c-di-GMP. MBP-PelD is chemically
cross-linked on gold surface and probed with either c-di-GMP at
5 mM (brown), 10 mM (purple) or 20 mM (cyan) or GTP at 5 mM
(yellow), 10 mM (pink) or 20 mM (blue) and washed away at times
indicated by the arrows.
A. MBP-PelD.
B. MBP-PelD (R367A).
C. MBP-PelD (D370A).
D. MBP-PelD (R402A).
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bind c-di-GMP (R367A, D370A and R402A) failed to
restore pellicle formation and did not bind Congo red. The
observed phenotype of the PelD mutants R367A, D370A
and R402A was not due to lower production of the
mutated forms of these proteins, as they are detectable
with an antibody to the HA tag (Fig. 5). These results
demonstrate a correlation between the ability of PelD to
bind c-di-GMP and its activity in vivo to participate in
pellicle formation.
Discussion
The cellular level of the second messenger c-di-GMP is
controlled by the reciprocal activities of diguanylate cycla-
ses and phosphodiesterases, which in many organisms
are encoded by a large number of paralogous genes. One
of the greatest challenges in the ﬁeld is to understand the
speciﬁcity and redundancy in the c-di-GMP regulatory
pathway. Are there speciﬁc DGCs/PDEs responsible for
activating or inhibiting speciﬁc pathways such as PEL
production? If so, the DGC and PDE proteins may colo-
calize with the c-di-GMP receptors to allow for even
greater sensitivity to signal generation by enhancing the
effects of local concentration. Results from overexpres-
sion of DGCs have suggested that high levels of c-di-
GMP results in functional redundancy as there is sufficient
amount of c-di-GMP to occupy all cellular receptors. To
establish the exact relationship of individual DGCs and
PDEs with speciﬁc c-di-GMP mediated phenotypes will
require the identiﬁcation of all c-di-GMP protein in an
individual organism.
Currently, only proteins with the PilZ domain have been
shown to bind c-di-GMP other than enzymes involved
in the metabolism of the dinucleotide. On metabolic
enzymes that produce and degrade c-di-GMP, there are
two sites that bind c-di-GMP including the putative regu-
latory domain of DGCs (Chan et al., 2004; Christen et al.,
2006) and the substrate-binding domains of PDEs. In this
article we presented the identiﬁcation of a c-di-GMP-
binding protein in P. aeruginosa that controls bioﬁlm
formation through the synthesis of an extracellular
polysaccharide encoded by the pel operon. We puriﬁed
each of the soluble fragments encoded by genes in the
pel operon and found that only one component, PelD,
speciﬁcally binds c-di-GMP. As the pel operon is con-
served in a number of bacterial species, we aligned all
PelD orthologues, identiﬁed conserved amino acids and
engineered mutations in the P. aeruginosa PelD in codons
for a number of conserved amino acids. Three mutations
in the C-terminus of PelD resulted in the loss of c-di-GMP
binding. When these three mutant PelD proteins were
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Fig. 5. Secondary structure prediction and consensus sequence of PelD and PleD.
A. Secondary structure predication was made using the web-based ProteinPredict program hosted at http://www.predictprotein.org/ for PelD
and PleD. The conﬁdence level of the prediction for each amino acid is located below the prediction. a-Helix and b-sheet elements pre-
dicted with a conﬁdence level of greater than 5 is depicted on the diagram. Conserved residues for PelD and PleD are shown above the
diagram and residues required for binding are shown in red. RxxD motif is indicated by the red box and GGEEF motif is in purple and is
underlined.
B. Consensus sequence of PelD and PleD was based on Phyre alignment of 20 and 100 homologues respectively. Residues required for
c-di-GMP binding is indicated in red, GGEEF motif is in purple and is underlined and other conserved residues are in green. RxxD motif is
indicated by the red box.
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strains were unable to form bioﬁlms and did not produce
the PEL polysaccharide. These results demonstrate that
binding of c-di-GMP to PelD is required for PEL polysac-
charide synthesis. Additional production of c-di-GMP can
increase binding to PelD and further activate PELpolysac-
charide synthesis, possibly in a mechanism similar to the
allosteric regulation of BcsA1 in activation of cellulose
synthase in G. xylinus (Weinhouse et al., 1997). Findings
from studies on PEL and alginate synthesis indicate that
each polysaccharide biosynthetic machinery requires
binding to c-di-GMP for activity and this mechanism of
regulation may be a general theme for all polysaccharide
biosynthetic systems regulated by c-di-GMP.
We have identiﬁed a c-di-GMP-binding protein that
mediates the signal transduction of c-di-GMP towards
expression of a surface polysaccharide. Bioinformatics
analysis of the PelD protein sequence reveals that the
protein secondary structure is comprised of alternating
a-helices and b-sheets, which is in marked contrast to the
PilZ domain that is comprised of four to ﬁve consecutive
b-sheets to form a b-barrel (Ramelot et al., 2007). Other
than PelD homologues in a limited number of bacterial
species, database searches have failed to identify addi-
tional genes that encode proteins with the c-di-GMP-
binding domain of PelD. Previously, Christen et al. (2006)
have characterized in C. crescentus PleD DGC the regu-
latory I-site, containing the RxxD sequence, as a binding
site for c-di-GMP and it is located six and nine amino acids
from the GGEEF motif involved in synthesis of c-di-GMP.
Although PelD and PleD are not related by primary
sequence, they both contain the conserved RxxD
residues. The similarities between the secondary struc-
ture of c-di-GMP-binding portion of PelD and the I-site of
PleD suggest certain degree of structural conservation.
Inspection of the structure of PleD for the location of the
I-site revealed that it is found in a small binding pocket,
which could function as the site for allosteric inhibition by
c-di-GMP. The c-di-GMP-binding motif of PelD may be
contained in such a similar pocket, but conﬁrmation of this
awaits structural determination of PelD. Nonetheless, the
differences in the remaining portion of the two proteins,
such as the lack of GGEEF motif in PelD, suggest
that c-di-GMP-binding proteins may be present in many
different proteins that lack sequence similarity to known
c-di-GMP receptors. Furthermore, the ﬂexibility in the
sequence of c-di-GMP-binding domains allows the poten-
tial of both positive and negative allosteric regulation on a
diverse set of proteins. This diversity of receptors for
c-di-GMP may provide a mechanism for generation of
speciﬁc responses following local production or degrada-
tion of this second messenger by the activities of multiple
DGCs and PDEs encoded in bacterial genomes. As c-di-
GMP binding is a requirement for the activation of a
number of polysaccharides required for bioﬁlm formation,
inhibition of c-di-GMP production or interaction with its
intracellular receptors presents attractive targets for the
development of antimicrobial therapeutic agents against
bioﬁlm-related diseases.
Experimental procedures
Strains, plasmids and media conditions
Strains, plasmids and primers used in this study are listed in
Tables S2, S3 and S4 respectively (Rahme et al., 1995).
In-frame deletion of retS, pelA, pelD and pelE in PA14 was
generated using the SOE strategy (Warrens et al., 1997). In
short, 1 kb ﬂanks of each gene were ampliﬁed by polymerase
chain reaction (PCR) with internal primers containing over-
lapping sequences. Puriﬁed fragments from the ﬁrst PCR and
external primers were then used for a second round of PCR
and the 2 kb product was cloned into pEX-Gn for integration
into PA14. The cointegrant is resolved by counterselection on
Luria–Burtani (LB) agar containing 6% sucrose and the dele-
tion was veriﬁed by PCR using the external primers.
P. aeruginosa strains were grown in LB broth. Plasmids
pMMB-Gn containing PA1107, PA1120 and PA3702 (Furste
et al., 1986; Kulasakara et al., 2006) as well as pelD and
PA14ΔpelD pDN19-PA3702
anti-HA
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Fig. 6. Residues required for c-di-GMP binding are required for
PEL polysaccharide synthesis. Complementation of the DpelD
mutation in PA14DpelD pDN19-PA3702 with pMMB containing
full-length pelD and indicated point mutations. Quantiﬁcation of PEL
polysaccharide binding to Congo red was normalized to total
protein for each strain. Pellicle formation for each stain was tested
in static culture and revealed by crystal violet staining. PelD and
mutant derivatives were fused at their C-termini to HA tags.
Total-cell extracts were prepared, loaded equally and separated on
SDS-PAGE, transferred to PVDF and PelD-HA was detected with
anti-HA antibody and chemiluminescence.
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-1 gen-
tamicin and expression was induced with 1 mM isopropylth-
iogalactose (IPTG). Plasmids pDN19 and pDN19-PA3702
are described elsewhere (Nunn and Lory, 1991; J.M.
Matewish, unpubl. data) and maintained with 15 mgm l
-1
tetracycline. All ampliﬁed DNA were veriﬁed by sequencing.
Crystal violet pellicle assay
EachstrainwasgrowninLBcontainingappropriateantibiotics
and IPTG as indicated in the text and incubated as a static
cultureat37°Cfor24 h.Theculturemediumwasremoved,the
pellicle was washed with water and stained with 50 mgm l
-1
crystal violet for 10 min, followed by the removal of unbound
crystal violet by washing 10 times with distilled water.
b-Galactosidase reporter assay
The promoter of the pel operon was cloned using primers
listed in Table S4 and cloned in front of lacZ gene in pCTX–
lacZ. The plasmid was integrated into the ctx site in the PA14
genome using the strategy described (Hoang et al., 1998).
P. aeruginosa strains containing the lacZ reporter were grown
in LB containing appropriate antibiotics and IPTG as indi-
cated in the text. b-Galactosidase activity is measured
according to an established method (Miller, 1992).
Congo red binding assay
The assay was adapted from Spiers et al. (2003). Each strain
was incubated in 1 ml of LB containing appropriate antibiotics
and IPTG as indicated in the text for 24 h at 37°C in 2 ml
microfuge tubes. The bacterial content was collected by cen-
trifugation, re-suspended in 1 ml of 40 mgm l
-1 Congo red in
1% tryptone and incubated for 90 min at 37°C at 250 r.p.m.
The bacteria and bound Congo red were collected by cen-
trifugation and the amount of Congo red remaining in the
supernatant was determined by measuring the absorbance of
the supernatant at 490 nm and compared with Congo red
standard solutions.
Protein expression and puriﬁcation
Coding sequences of full-length PelA, PelC lacking its signal
sequence (amino acids 16–172), the cytosolic fragments of
PelD (amino acids 105–455), PelE (amino acids 95–329) and
full-length PelF were ampliﬁed using the indicated primers
by PCR, excised with appropriate restriction enzymes and
cloned into pVL847 behind the 6-histidine-MBP tag. pelD
point mutations were generated by QuikChange (Strategene,
San Diego) using the following primer pairs described in
Table S3. pVL847 and derivative plasmids were transformed
into BL21. Expression of MBP and fusion proteins were
induced by IPTG, puriﬁed over Ni-NTA agarose (Qiagen,
California) and eluted by 250 mM imidazole. The imidazole is
removed by PD10 desalting column (GE Healthcare, New
Jersey) equilibrated with buffer containing 10 mM Tris, pH 7.4
and 100 mM NaCl. Proteins were aliquoted and frozen in
liquid nitrogen.
[32P]-c-di-GMP binding assay
[
32P]-c-di-GMP is generated from [a-
32P]-GTP using puriﬁed
WspR. Each puriﬁed protein (1 mg ml
-1) was incubated with
100 nM of [
32P]-c-di-GMP for 30 min at 20°C with 100 mlo fa
50% slurry of Ni-NTA agarose beads in 10 mM Tris, pH 7.4
and 100 mM NaCl. For competition experiments, various
concentration of each indicated inhibitor is added after incu-
bation of protein with [
32P]-c-di-GMP and incubated for an
additional 30 min. The beads with bound protein were col-
lected by centrifugation and the supernatant was transferred
to an empty microfuge tube for unbound [
32P]-c-di-GMP. The
beads were washed twice with 50 ml of 10 mM Tris, pH 7.4
and 100 mM NaCl and each wash was transferred to the
same unbound [
32P]-c-di-GMP tube. Both fractions were
counted in the scintillation counter with a total of 500 000
counts in each sample. The percentage [
32P]-c-di-GMP
bound is calculated as 100 ¥ the counts retained with the
agarose beads divided by the sum of all counts.
Surface plasmon resonance
All experiments were performed using a Bio-Rad ProteoOn
XPR36 Protein Interaction array system. Each puriﬁed
protein (1 mg ml
-1) was cross-linked onto the surface of GLM
chip using sulfo-NHS. The reaction was quenched with
glycine and unbound protein is removed by washing. The
amount of cross-linked protein was determined by change in
molecular weight of the surface as RU. Solution of c-di-GMP
or GTP at 5, 10 and 20 mM was passed over each spot of the
chip and the change in molecular weight was detected.
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